Clover Health Investments, Corp. CLOV
Institutional shares held
116 Million
7.3M
calls
3.34M
puts
Total value of holdings
$287M
$18M
calls
$8.25M
puts
Market Cap
$947M
383,248,000
Shares Out.
Institutional ownership
30.28%
# of Institutions
239
We take great care to ensure that the data presented and summarized in this overview for CLOVER HEALTH INVESTMENTS, CORP. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CLOV
View all-
Vanguard Group Inc Valley Forge, PA23.1MShares$57 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.72MShares$24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.54MShares$23.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.95MShares$22.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.71MShares$19.1 Million0.03% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA4.46MShares$11 Million0.01% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.27MShares$10.6 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL3.37MShares$8.33 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL2.77MShares$6.84 Million0.51% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA2.7MShares$6.67 Million0.0% of portfolio
Latest Institutional Activity in CLOV
Top Purchases
Top Sells
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Insider Transactions at CLOV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,655,949
-47.15%
|
$3,311,898
$2.59 P/Share
|
|
Jan 07
2026
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,655,949
+32.04%
|
-
|
|
Jan 07
2026
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
2,102
-0.08%
|
$4,204
$2.53 P/Share
|
|
Jan 06
2026
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+11.58%
|
-
|
|
Jan 06
2026
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+18.37%
|
-
|
|
Jan 06
2026
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+11.72%
|
-
|
|
Jan 06
2026
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+13.08%
|
-
|
|
Jan 06
2026
|
Thomas L Tran Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+30.6%
|
-
|
|
Jan 03
2026
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,109
-0.29%
|
$16,218
$2.41 P/Share
|
|
Jan 01
2026
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
267,958
-2.72%
|
$535,916
$2.35 P/Share
|
|
Dec 18
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
4,913
-0.18%
|
$9,826
$2.61 P/Share
|
|
Dec 15
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.31%
|
$17,382
$2.7 P/Share
|
|
Dec 15
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,404
-0.52%
|
$12,808
$2.7 P/Share
|
|
Dec 14
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
12,567
-0.45%
|
$25,134
$2.7 P/Share
|
|
Dec 14
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
98,411
-8.56%
|
$196,822
$2.7 P/Share
|
|
Nov 14
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
7,459
-0.6%
|
$14,918
$2.47 P/Share
|
|
Nov 08
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,535
-0.86%
|
$171,070
$2.67 P/Share
|
|
Nov 04
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
30,385
-1.08%
|
$91,155
$3.58 P/Share
|
|
Oct 31
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
111,691
-2.41%
|
$335,073
$3.53 P/Share
|
|
Oct 31
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
169,607
-6.17%
|
$508,821
$3.53 P/Share
|
Last 12 Months Summary
Buy / Acquisition
3.07M
Shares
From
10
Insiders
| Grant, award, or other acquisition | 941K shares |
|---|---|
| Exercise of conversion of derivative security | 1.66M shares |
| Open market or private purchase | 473K shares |
Sell / Disposition
7.21M
Shares
From
12
Insiders
| Payment of exercise price or tax liability | 6.56M shares |
|---|---|
| Open market or private sale | 647K shares |